These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 38540265)

  • 1. Incretin Hormone Secretion in Women with Polycystic Ovary Syndrome: Roles of Obesity, Insulin Sensitivity and Treatment with Metformin and GLP-1s.
    Etrusco A; Mikuš M; D'Amato A; Barra F; Planinić P; Goluža T; Buzzaccarini G; Marušić J; Tešanović M; Laganà AS
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists.
    Cena H; Chiovato L; Nappi RE
    J Clin Endocrinol Metab; 2020 Aug; 105(8):e2695-709. PubMed ID: 32442310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence.
    Abdalla MA; Deshmukh H; Atkin S; Sathyapalan T
    Ther Adv Endocrinol Metab; 2021; 12():2042018821989238. PubMed ID: 33552465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis.
    Han Y; Li Y; He B
    Reprod Biomed Online; 2019 Aug; 39(2):332-342. PubMed ID: 31229399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome.
    Tzotzas T; Karras SN; Katsiki N
    Curr Vasc Pharmacol; 2017; 15(3):218-229. PubMed ID: 28003008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-sensitizing agents for infertility treatment in woman with polycystic ovary syndrome: a narrative review of current clinical practice.
    Sparić R; Andjić M; Rakić A; Bjekić-Macut J; Livadas S; Kontić-Vučinić O; Mastorakos G; Macut D
    Hormones (Athens); 2024 Mar; 23(1):49-58. PubMed ID: 37792213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS.
    Bader S; Bhatti R; Mussa B; Abusanana S
    Womens Health (Lond); 2024; 20():17455057241234530. PubMed ID: 38444070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome.
    Siamashvili M; Davis SN
    Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1081-1089. PubMed ID: 34015974
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS.
    Xing C; Li C; He B
    J Clin Endocrinol Metab; 2020 Sep; 105(9):2950-63. PubMed ID: 32490533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice: Compared Evaluation of Liraglutide and Semaglutide Intervention.
    Xiong C; Wu J; Ma Y; Li N; Wang X; Li Y; Ding X
    Diabetes Metab Syndr Obes; 2024; 17():865-880. PubMed ID: 38406269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review.
    Xie Z; Hu J; Gu H; Li M; Chen J
    Front Endocrinol (Lausanne); 2023; 14():1244432. PubMed ID: 37701904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects and plasma proteomic analysis of GLP-1RA versus CPA/EE, in combination with metformin, on overweight PCOS women: a randomized controlled trial.
    Liao M; Li X; Zhang H; Zhou L; Shi L; Li W; Shen R; Peng G; Zhao H; Shao J; Wang X; Sun Z; Zheng H; Long M
    Endocrine; 2024 Jan; 83(1):227-241. PubMed ID: 37653215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost-effectiveness of six GLP-1RAs for treatment of Chinese type 2 diabetes mellitus patients that inadequately controlled on metformin: a micro-simulation model.
    Yuan S; Wu Y
    Front Public Health; 2023; 11():1201818. PubMed ID: 37744474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
    Lyu X; Lyu T; Wang X; Zhu H; Pan H; Wang L; Yang H; Gong F
    Int J Endocrinol; 2021; 2021():6616693. PubMed ID: 33679973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
    Pugliese G; de Alteriis G; Muscogiuri G; Barrea L; Verde L; Zumbolo F; Colao A; Savastano S
    J Endocrinol Invest; 2023 Sep; 46(9):1761-1774. PubMed ID: 37093453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Oral Antidiabetic Drugs on Improving the Endocrine and Metabolic States in Women with Polycystic Ovary Syndrome: A Systematic Review and Network Meta-analysis.
    Yang S; Zhao L; He W; Mi Y
    Drugs; 2022 Sep; 82(14):1469-1480. PubMed ID: 36129662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies.
    Szczesnowicz A; Szeliga A; Niwczyk O; Bala G; Meczekalski B
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective.
    Jensterle M; Janez A; Fliers E; DeVries JH; Vrtacnik-Bokal E; Siegelaar SE
    Hum Reprod Update; 2019 Jul; 25(4):504-517. PubMed ID: 31260047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLP-1 Receptor Agonists: Practical Considerations for Clinical Practice.
    Triplitt C; Solis-Herrera C
    Diabetes Educ; 2015 Dec; 41(1 Suppl):32S-46S. PubMed ID: 26450217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.